ENvue Medical (FEED) Current Deferred Revenue (2021 - 2025)

ENvue Medical (FEED) has reported Current Deferred Revenue for 5 consecutive years, with $175000.0 the latest figure, recorded in Q4 2025.

• On a quarterly basis, Current Deferred Revenue rose 1066.67% year-over-year to $175000.0 in Q4 2025; TTM through Dec 2025 was $175000.0, a 1066.67% increase from a year earlier, with the FY2025 full-year figure at $175000.0, up 1066.67% from the prior year.
• Current Deferred Revenue was $175000.0 for Q4 2025 at ENvue Medical, up from $4000.0 in the prior quarter.
• Over five years, Current Deferred Revenue peaked at $175000.0 in Q4 2025 and troughed at $4000.0 in Q1 2025.
• A 5-year average of $51692.3 and a median of $44000.0 in 2021 frame the typical range for Current Deferred Revenue.
• The widest YoY moves for Current Deferred Revenue: up 1066.67% in 2025, down 91.3% in 2025.
• Over 5 years, Current Deferred Revenue stood at $44000.0 in 2021, then tumbled by 52.27% to $21000.0 in 2022, then surged by 119.05% to $46000.0 in 2023, then tumbled by 67.39% to $15000.0 in 2024, then jumped by 1066.67% to $175000.0 in 2025.
• The last three Current Deferred Revenue figures came in at $175000.0 (Q4 2025), $4000.0 (Q1 2025), and $15000.0 (Q4 2024), per Business Quant data.